A Double-Blind, Randomized, Single Center, two-Sequence, four-Period, Two treatment Crossover Glucose Clamp Study to Evaluate Pharmacokinetics and Pharmacodynamics Following Two Single Subcutaneous Doses of Insulin Glargine Injection with Lantus® Injection in Healthy Subjects.

Trial Profile

A Double-Blind, Randomized, Single Center, two-Sequence, four-Period, Two treatment Crossover Glucose Clamp Study to Evaluate Pharmacokinetics and Pharmacodynamics Following Two Single Subcutaneous Doses of Insulin Glargine Injection with Lantus® Injection in Healthy Subjects.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Insulin glargine (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Wockhardt
  • Most Recent Events

    • 01 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top